IL22RA1 and COVID-19: We focused on the dynamics of the immune cells in the blood in parallel to the alterations of IL-22R1 expression on these cells in non-severe and severe COVID-19 patients without any corticosteroid treatment as they were recruited during the first wave of the pandemic.